Zambia's Cannabis Export Law vs. St. Vincent's Rasta Amnesty
Photo by NickyPe via Pixabay.
Zambia's cabinet did something in December 2019 that got almost no coverage outside trade publications: it voted, unanimously, to let cannabis be grown and exported legally. Two years later, that decision became law when Zambia's government pushed through the Cannabis Act No. 33 of 2021. On paper, Zambia joined a small club of African nations opening a licensed cannabis export lane. In practice, nothing changed for the roughly one in five Zambian adults who already use the plant, because possession stayed exactly as criminal as it was under colonial-era drug statutes. That gap -- between a law built for export revenue and a population still policed under older, harsher rules -- is the story.
Nearly 5,000 miles away, on a string of volcanic islands in the eastern Caribbean, St. Vincent and the Grenadines took the same basic policy problem and answered it almost backwards. When its Parliament wrote the Medicinal Cannabis Industry Act in December 2018, lawmakers paired it with a second bill: an amnesty act, built specifically to bring existing Rastafari growers -- people who had been cultivating cannabis in the hills for generations, often facing arrest for it -- into the new legal industry rather than locking them out of it.
Both countries are small, agriculture-reliant economies trying to turn a plant long treated as contraband into a licensed export commodity. Both answer to the same international drug treaties. But who actually gets a license, a seat at the table, a legal livelihood -- that's where Zambia and St. Vincent diverge sharply, and the divergence has less to do with the plant itself than with how each government chose to write its licensing rules.
Zambia's Legal Patchwork: From the Dangerous Drugs Act to the 2021 Cannabis Act
Cannabis wasn't a legal blank slate in Zambia before 2021. The Dangerous Drugs Act, Cap. 95, had already folded cannabis into the same regulatory bucket as opium, coca leaves and poppy-straw, requiring a ministerial import license for any legal movement of the substance. That statute reflected a mid-20th-century approach to drug control -- restrict everything uniformly, license nothing meaningfully -- and it stayed on the books largely untouched for decades.
The December 2019 cabinet vote changed the political direction, though not the underlying criminal code. Cabinet approved cannabis cultivation strictly for export and medicinal purposes, explicitly ruling out any loosening around domestic recreational use. That distinction -- export and medicine, yes; personal use, no -- became the spine of everything that followed.
The Cannabis Act No. 33 of 2021, assented to on 19 May 2021, formalized the cabinet's position into statute. It did something notable on the international side too: the Act explicitly domesticates Zambia's obligations under the 1961 Single Convention on Narcotic Drugs, the foundational UN treaty that most countries' cannabis laws still have to answer to in some form. Writing treaty compliance directly into domestic law wasn't just legal housekeeping -- it signaled to international investors and trading partners that Zambia's cannabis exports would meet the same scheduling and control standards as any other treaty signatory.
The Act also named a regulator: the Zambia Medicines and Medical Supplies Agency, referenced in ministerial statements by the acronym ZAMRA, became the Lead Agency responsible for licensing any medicinal, scientific or research cannabis activity. That's a pharmaceutical regulator, not an agricultural extension office or a rural development agency -- a structural choice that tells you a lot about who the law imagined applying for licenses. The whole framework was engineered around export revenue and satisfying international drug-control obligations. It was not built, at any point in its drafting, to change how an ordinary Zambian who grows or smokes cannabis gets treated by police.
A $250,000 Bottleneck: Why Zambia's Licenses Still Don't Exist
Five years after the Cannabis Act became law, ZAMRA still hasn't issued a single operational commercial cannabis license. Not one. For a country that positioned itself as an emerging export player in 2019, that's a striking stall -- and the reasons are baked into the licensing structure itself.
The commercial license fee sits at $250,000 per year, and that figure is just the entry cost -- applicants also have to go through a competitive bidding process on top of it. For context, that's more than most Zambian agricultural cooperatives will see in cumulative annual revenue, let alone have sitting in reserve to pay a regulator before a single plant goes in the ground. It's a fee schedule written for multinational agribusiness or well-capitalized foreign investors, not for the smallholder farmers who make up the backbone of Zambian agriculture generally.
ZAMRA itself seems aware the rollout has stalled. Its 2022-2026 Strategic Plan lists cannabis and hemp regulation as a stated institutional priority -- language that suggests the agency knows this is unfinished business. But listing a priority on a strategic plan and actually issuing licenses are different things, and the gap between the two has now stretched across nearly the entire five-year window that plan covers.
Meanwhile, the payoff being chased isn't even that large. Market analysts project Zambia's legal cannabis sector will reach roughly US$27.70 million in volume by 2029, growing at a compound annual rate of just 1.95%. That's a modest ceiling for a licensing regime this expensive to enter -- and it raises a real question about whether the $250,000 fee is calibrated to the size of opportunity it's gatekeeping, or simply calibrated to keep the field narrow. Either way, the structural effect is the same: a law aimed squarely at large, capitalized operators, with no built-in lane for small-scale or traditional Zambian cultivators to enter the legal market at all.
The Paradox: High Consumption, Harsh Penalties

Photo by jhusemannde via Pixabay.
Here's the number that makes Zambia's cannabis law look almost surreal: by some estimates, 18.3% of Zambian adults use cannabis, placing the country third highest globally on a per-capita basis. This isn't a fringe substance in Zambian life -- it's woven into rural cultivation practices and urban consumption patterns alike, likely predating any of the export licensing conversation by generations.
And yet none of that consumption is legal. While the Cannabis Act opened a regulated channel for export and medicine, it left the older criminal framework fully intact for personal use. Possession of even 0.5 grams -- a genuinely tiny amount, well under what most users would consider a single dose in flower form -- can trigger prosecution under existing drug law. There's no decriminalization threshold, no diversion program tied to the new Act, no softened penalty structure that mirrors the government's newly warm posture toward cannabis as a commodity.
What that produces is a two-tier system operating in plain sight. Cannabis is, simultaneously, a sanctioned and internationally compliant export commodity available to whichever well-capitalized entity eventually clears ZAMRA's $250,000 bar -- and an arrestable offense for the ordinary Zambians who have been growing and using it informally, in some cases for their entire lives, with no legal pathway offered to them at all.
That gap -- between what the law permits for licensed corporate players and what it still criminalizes for everyone else -- is the actual crux of Zambia's cannabis paradox. It's not that the country legalized cannabis; plenty of countries have done that unevenly. It's that the unevenness maps almost perfectly onto who already has capital and who doesn't. And it's precisely this gap that St. Vincent and the Grenadines set out to close, deliberately, when it wrote its own cannabis law three years earlier.
St. Vincent's Alternative: Writing Amnesty Into the Statute

Photo by Fadhil Abhimantra via Unsplash.
St. Vincent and the Grenadines didn't pass one cannabis law in December 2018 -- it passed two, on purpose, as companion legislation. The Medicinal Cannabis Industry Act built the commercial licensing framework, the export-facing half of the equation that looks structurally similar to what Zambia would attempt three years later. But sitting right alongside it was the Cannabis Cultivation (Amnesty) Act, and that second bill is where the real policy divergence starts.
The Amnesty Act created something Zambia's law never bothered to include: a specific legal category called the traditional cultivator's licence, reserved for Vincentian citizens who were already growing cannabis before the new law existed. Instead of starting the industry from a blank slate and inviting anyone with enough capital to bid for entry, SVG's Parliament looked at who was already doing the work -- largely Rastafari farmers who had been cultivating in the hills for decades, often under threat of arrest -- and built a legal on-ramp specifically for them.
That on-ramp has kept producing real names on real license rolls. As of a June 2025 update, licenses had gone to Rastafari organizations including the Nyahbinghy Order of Rastafari, RastafariFarms, the Cannabis Revival Committee, SVG RastafariAgri, and the Grieggs Rastafari progressive society. These aren't abstract categories in a regulatory strategy document -- they're named community organizations now operating inside the legal industry.
The Medicinal Cannabis Authority has projected that roughly 200 more traditional cultivators would receive licenses by September, steadily widening the base of legally recognized small growers rather than letting the market consolidate around a handful of large operators. And there's a mechanism forcing that inclusion to matter economically: commercial cannabis companies operating in SVG are required to buy 10% of their plants from traditional cultivators. That's not a symbolic gesture -- it's a built-in demand channel that ties corporate profitability directly to small-grower participation, guaranteeing the traditional cultivators an actual market rather than just a legal status with nowhere to sell.
Two Models, One Question: Who Gets Legalized?

Photo by Naitian(Tony) Wang via Unsplash.
Line the two models up side by side and the contrast is almost too clean. Zambia's approach is top-down and export-first: a pharmaceutical regulator, a $250,000 annual license fee, a competitive bidding process, all engineered to attract outside capital and satisfy the reporting expectations of the 1961 Single Convention. St. Vincent's approach is bottom-up and inclusion-first: amnesty for people already growing the crop, licenses issued to named Rastafari organizations, and a purchasing quota that legally obligates commercial growers to buy from small cultivators rather than simply outcompete them.
What makes the comparison worth dwelling on is that both countries are working under the exact same international treaty framework. The Single Convention doesn't tell Zambia to set a six-figure license fee, and it doesn't tell St. Vincent to carve out a traditional cultivator's licence. Treaty compliance sets the outer boundaries -- scheduling, export controls, reporting obligations -- but the licensing design inside those boundaries is entirely a domestic political choice. Zambia chose capital. St. Vincent chose its existing growers.
To Zambia's credit, ZAMRA's own strategic plan suggests some institutional awareness that the current setup has a gap in it -- cannabis and hemp regulation is flagged as an ongoing priority, not something the agency considers finished or fine as-is. But awareness and design are different things, and as of 2026 there is still no Zambian equivalent to SVG's traditional cultivator pathway written into law. No amnesty category, no reserved licensing tier, no purchasing quota tying big operators to small growers.
The comparison points toward an obvious, almost low-cost template Zambia hasn't used yet: take the small-scale, often informal cultivators who already grow cannabis across the country and give them a legal categorization and a guaranteed market niche, the way Vincentian Rastafari growers got folded into SVG's industry instead of being treated as background noise to the export licensing conversation happening above their heads.
There's a difference between legalizing something on paper and legalizing it in practice, and Zambia is a textbook case of getting stuck in that gap. Five years after the Cannabis Act No. 33 of 2021 received presidential assent, the country still has zero operational commercial licenses, a consumer population that's among the most cannabis-engaged on earth, and a possession threshold so low that a fraction of a gram can put someone in front of a magistrate. The export ambition is real. The domestic reckoning hasn't started.
St. Vincent and the Grenadines didn't solve every problem with its 2018 legislation, and its market is a fraction the size of what Zambia is chasing. But the amnesty act and the 10% purchasing quota prove something worth taking seriously: a small nation, working under the same international drug treaties as everyone else, can choose to design its licensing regime around the people who already grow the crop instead of around whoever can write the biggest check. That's not a radical or untested idea at this point -- it's operating, with named Rastafari organizations holding licenses right now.
Zambia still has a choice to make, and the timing of that choice matters more than it might seem. If foreign capital locks up the export market before any traditional-cultivator pathway gets written into law, the informal growers who've been cultivating cannabis in Zambia for generations will likely stay exactly where they are now -- outside a legal industry built, quite literally, in their own backyard.



